We have examined the responses of energy and protein metabolism to nutrient intake in nine patients with lung carcinoma, of whom none Â»ere cachexie and only one had distant mÃ©tastases,compared with nine control patients for elective aneurism surgery, who were comparable in terms of age, body mass index, and smoking habits. Whole-body protein turnover and leucine oxidation were assessed by primed continuous infusion of i |"C|leucine. Indirect calorimetry was used to determine energy expendi ture and rates of carbohydrate and fat utilization. Lean body mass (IHM) was estimated from dilution of deuterium oxide. Measurements were made over an 8-h period, including 4 h postabsorptive followed by 4 h of feeding, during which small hourly meals were consumed. In the postabsorptive state, the rate of incorporation of leucine into protein was higher in the cancer group (mean Â±SD, cancer versus control: 102 Â±21 versus 86 Â±8 /Â¿mol/kg LBM/h, P < 0.05), as was the release of leucine by protein degradation (126 Â±19 versus 110 Â±10 Mmol/kg LBM/h, P < 0.01), but there was no difference in rates of leucine oxidation (27 Â±6 versus 27 Â±5 Mmol/kg LBM/h) or leucine balance (â€"25Â±7 versus â€"¿ 24 Â±4 /niKil ky LBM/h). There were no differences between the cancer and control groups with respect to either resting energy expenditure (37.3 Â± 3.5 versus 35.2 Â±3.8 kcal LBM/day) or the postabsorptive pattern of nutrient utilization (61 Â±13% fat, 26 Â±10% carbohydrate, and 13 Â±2% protein versus 65 Â±7%, 21 Â±7%, and 14 Â±2%, respectively). During feeding, leucine oxidation rose relative to the postabsorptive state, incor poration into protein remained the same, and release by protein degra dation fell. Incorporation (106 Â±20 versus 89 Â±7 Mmol/kg LBM/h, P < 0.05) and release (59 Â±12 venus 42 Â±14 Mmol/kg LBM/h, P < 0.02) remained higher in the cancer group than in controls, but leucine oxidation (43 Â±15 versus 43 Â±12 Mmol/kg LBM/h) and leucine balance (+48 Â± 10 versus +47 Â±12 Mmol/kg LBM/h) were the same. Energy expenditure during feeding increased to 43.8 Â±5.1 versus 43.2 Â±4.2 kcal/kg LBM/ day, derived from 32 Â±11% fat, 52 Â±9% carbohydrate, and 16 Â±5% protein in cancer patients and 36 Â± 7%, 48 Â±8%, and 16 Â±4%, respectively, in controls. I luis, newly diagnosed lung cancer patients showed increased protein turnover rates expressed per kg LBM, despite no detectable effect on leucine balance and energy expenditure or on their responses to food intake. Furthermore, these elevated rates of protein turnover were apparent in noncachexic patients and were shown not to depend on the presence of mÃ©tastases.
INTRODUCTION
Weight loss associated with cancer may exacerbate the sever ity of the disease by depleting body reserves of protein and of energy. Any loss of weight must arise from an inability of dietary intake to meet the metabolic demands for energy ex penditure or obligatory loss of body nitrogen. Energy expendi ture in cancer patients has been assessed by several groups and has been found to be higher than in control patients (1) (2) (3) . However, these studies have not allowed for alterations in metabolic rate which might arise from an altered proportion of lean to fat tissue. Hansell and colleagues (4) have recently 2To whom requests for reprints should be addressed.
shown that there is no difference in resting energy expenditure if individuals who have lost weight from either benign or malignant cause, if energy expenditure is related to lean body mass.
Depletion of body protein in cancer patients, manifest as muscle wasting and lowering of plasma proteins (5) , has been shown in a number of studies to be associated with increased rates of whole-body protein turnover (6) (7) (8) (9) (10) (11) , although this finding has not been universal. Some studies have shown no increase in turnover (12) (13) (14) , and it has been suggested that increases might only occur when there is metastatic spread of the disease (8, 10) and in fasting rather than fed subjects (15) . Furthermore, as measured rates have been related to total body mass rather than lean body mass, it has not been shown that the elevated rate of turnover does not result from an increase in the proportion of lean to fat tissue.
The loss of lean body mass in cancer-bearing states has led to the use of nutritional support, in an attempt to meet poten tially enhanced dietary requirements for protein and energy. Intravenous nutrition has been shown to improve protein bal ance in cancer patients (16. 17) . However, similar improvement could be obtained with enterai feeding at a lower nitrogen level (17) . As parenteral nutrition is unlikely to be used in most cancer patients, it seems pertinent to examine whether patients with carcinoma respond normally to oral intake of ordinary food, from the point of view of both protein turnover and energy metabolism.
This study was performed in patients with newly diagnosed carcinoma of the lung, who were without gastrointestinal upset and were noncachexic, but in whom weight loss was beginning to be manifest. A combined approach for assessing rates of energy expenditure, nutrient utilization, and protein metabo lism was used, employing the method of constant infusion of stable isotopically labeled leucine, together with indirect calo rimetry. The study was designed to answer the question whether cancer patients are abnormal in their acute responses of protein and energy metabolism to food intake, as well as in the postabsorptive state. Additionally, we asked whether any differences in metabolism are linked to changes in body composition, assessed by measurements of body water content with D:O, and whether they occur in patients without metastatic spread of the disease.
PATIENTS AND METHODS
Patients with newly diagnosed carcinoma of the lung were recruited from the thoracic surgical unit. All subjects were ambulant and were undergoing investigations routinely used for accurate staging of their disease. Inoperability (mediastinal invasion or disease beyond the chest) was not a ground for exclusion from the study. Control patients recruited from the vascular unit were about to undergo aortofemoral reconstructions for asymptomatic aneurysmal disease. They were in good general health and had similar smoking habits to the cancer patients. No subject had any other chronic metabolic disease, and all were physically fit at the time of study. All subjects gave signed consent to the study, which was conducted with the permission of the Joint 1125 Ethical Committee of the Grampian Health Board and the University of Aberdeen.
Each subject was weighed to 0.02 kg and height was recorded to 0.5 cm. Total body water was estimated for each subject in the fasting state from the 3-h plasma dilution of an oral dose of deuterium oxide (99.8 atom %\ Sigma, Poole, Dorset, United Kingdom), given at 0.17 g/liter body water estimated from regression equations (18) . Samples were analyzed in triplicate by isotope-ratio mass spectrometry (SIRA 10; VG Isogas, Middlewich, Cheshire, United Kingdom), and total body water was calculated ( 19. 20) . LBM-' was calculated as total body water/ 0.73, assuming constant lean tissue hydration of 73% (21) . Estimates of total energy and protein intakes for each patient were made for both the habitual diet at home by dietary history and for the hospital diet consumed on the day before the study by 24-h recall, with the aid of hospital menu cards. These estimates were quantitated by assigning standard portion sizes, using a locally available mainframe computer facility adapted for dietary survey work (22) .
After an overnight fast, patients underwent the experimental protocol illustrated in Fig. 1 , involving an 8-h period during which rates of protein turnover and energy metabolism were measured. This included 4 h fasted (postabsorptive) followed by 4 h during which small hourly meals were given (fed). The standard meals were prepared from bread, margarine, cheese, raisins, and milk with an allowance of tea or coffee, and each provided one-twelfth of the daily energy expenditure, calcu lated as 1.5 x basal metabolic rate estimated from regression equations of weight, age, and height (23) . These provided energy in the propor tions 12.5% protein, 33.0% fat, and 54.5% carbohydrate (24) .
Whole-body protein turnover was estimated from leucine kinetics, measured by constant infusion of L-[l-"]leucine (99 atom %; Tracer Technologies, Somerville, MA), as previously described (25) . The in fusion of ("Cjleucine was given into a forearm vein at 2.3 Â¿imol/kg-h, immediately preceded by priming doses of both ("CJleucine (1.9^mol/ kg) and sodium ["Cjbicarbonate (1.73 /jmol/kg, 99 atom %; Tracer Technologies. The timing of forearm venous blood samples taken from the contralateral arm and of breath samples is shown in Fig. 1 . Isotopie enrichments of ["CJleucine and ["C]Â«-ketoisocaproic acid (the deamination product of leucine) in plasma and of breath "CO2 were measured by gas chromatography mass spectrometry and gas isotope ratio mass spectrometry, as before (25) . During the sampling periods, while the subject reclined on an ordinary hospital bed under a 1000-litre plastic tent, the CO2 production and O2 consumption were monitored. A correction was made for the incomplete recovery of labeled CO2 in the breath and for ' 'CO2 arising from the diet (25, 26) , using values obtained with the same equipment and experimental protocol. Rates of wholebody leucine metabolism were calculated by a stochastic method (27) , using plasma ["CJleucine enrichment to calculate flux and plasma enrichment of [UC]KIC to calculate leucine oxidation (25) (although the conclusions were not altered if KIC was used to calculate both flux and oxidation). Rates of incorporation of leucine into body protein (protein synthesis) were obtained from the difference between flux and oxidation, whereas rates of release of leucine by breakdown of body protein were calculated as the difference between flux and the combined rate of dietary leucine intake and tracer infusion. The leucine content 3The abbreviations used are: LBM. lean body mass: REE. resting energy expenditure: BMI. body mass index: KIC, ('''Cla-ketoisocaproic acid.
of each food in the diet was obtained from food tables (28). This procedure was verified by amino acid analysis after acid hydrolysis of a homogenized, freeze-dried meal. Fat and carbohydrate utilization were calculated from the respiratory gas exchange and the rates of leucine oxidation according to the method of Garlick (26. 28 ). which takes account of differences in composition of body fat and protein from dietary fat and protein.
Plasma insulin concentrations were measured by an in-house double antibody assay and leucine levels by quantitative mass spectrometry.
Results for each subject were computed for the periods 2.5-4 h and 6-8 h, corresponding to the postabsorptive and fed states, respectively (26) . Statistical comparisons between postabsorptive and fed states were made by paired t tests. Comparisons between cancer and control patients were made by Mann-Whitney U tests because of inequality of variances in the two groups.
RESULTS
AnthropomÃ©trie indices are shown for the cancer group in Table 1 and for the control group in Table 2 . There was no significant difference between cancer and control patients for height, weight, and BMI. There were also no differences in hemoglobin, white blood cell count, albumin, or alkaline phosphatase (data not shown). This was true for both the complete groups and for males/females separately. No control patient reported recent weight loss; in the cancer group, four of Five females and two of four males recollected weight loss. Despite the loss of weight in the cancer group and the slightly lower BMI, there was no significant difference in the lean body mass, estimated by heavy water dilution. These values for LBM were used in calculating rates of protein and energy metabolism per kg LBM (see below).
The histolÃ³gica! diagnoses and staging of carcinoma patients are listed in Table 3 . In five patients, there was lymph node involvement and in six patients there was local invasion, but only one patient had distant mÃ©tastases(liver and lung, patient 7).
During the leucine infusions, concentrations of leucine and enrichments of plasma leucine and KIC and breath CO2 became constant during the hours 2.5-4 (fasted) and 6-8 (fed), as shown previously (25, 26) . The quality of the plateaus was similar to that reported previously (25, 26) . For both groups of subjects, the plateaus were verified by multiple regression analysis, show ing that slopes were not significantly different from zero (25) . During the experimental period, peripheral venous concentra tions of leucine were lower in the cancer group than in controls at all time points, but only significantly so at 2 h (122.2 Â±17.3 and 139.6 Â±16.7 Â¿Â¿mol/liter, respectively, P < 0.05). In both groups, plasma insulin levels were significantly higher during feeding (P < 0.001) than fasting, but there was no difference between groups in either nutritional state. Rates of whole-body protein turnover determined from leucine kinetics are shown for each cancer patient in Table 4 and for each control patient in Table 5 . In the postabsorptive state, leucine flux, protein synthesis, and protein breakdown were all higher in the cancer group than in the controls. There was no difference in leucine oxidation between the cancer patients and controls.
In both groups, feeding caused significant increases in leucine flux and oxidation, a significant decrease in breakdown, but no change in protein synthesis by comparison with the postabsorp tive state. However, both synthesis and breakdown remained significantly higher in the cancer group than in the controls. Despite the higher protein turnover rates in the cancer patients, the overall leucine balance was the same in both the fasted and fed states (Fig. 2) cancer group were examined in relation to the patients' esti mates of weight loss by Spearman rank correlation, there was no significant relationship between weight loss and any com ponent of protein turnover shown in Table 4 .
The energy expenditure of the cancer group did not differ from the control group in either the postabsorptive or fed state.
nor was there any difference in respiratory quotient (Tables 6  and 7 ). In the postabsorptive state, oxidation of fat was the predominant energy source, with carbohydrate and protein providing smaller proportions, but there were no significant differences between groups (Tables 8 and 9 ). During feeding, there was a switch toward carbohydrate as the principal energy source, but the pattern of fat, carbohydrate, and protein utili zation in the cancer patients was not significantly different from that in controls (Tables 8 and 9 ).
The habitual diet consumed by the cancer patients was esti mated to consist of 39.8 Â±10.9 kcal/kg LBM/day and 1.77 Â±' 0.60 g protein/kg LBM/day. This was not significantly different from control subjects, who habitually ate 37.4 Â±16.0 kcal/kg LBM/day and 1.67 Â±0.83 g protein/kg LBM/day. The esti mated protein and energy consumed in hospital on the day before the study was also not significantly different from the habitual diet for either cancer patients or controls.
DISCUSSION
In healthy people the normal pattern of food intake and absorption involves periods of fasting followed by the consump- Table 4 Rates of protein turnover determined from leiieine kinetics for each patient with lung carcinoma (vmol leucine/kfi LBM/h) Mean value during feeding significantly different from postabsorptive value: a, P < 0.01; b, P < 0. 001 Table 5 Rates of protein turnover determined from leucine kinetics for each control patient (inmol leucine/kg LBM/h) Mean value during feeding significantly different from postabsorptive value: a, P< 0.002; b, P< 0.001. Mean value in control patients significantly different from the equivalent value in cancer patients (fable 4): c. 0.05 < P < O.I; d, P < 0.05: e. P < 0.02: f. P < 0.01. Letters in parentheses indicate the significance of the difference between control and cancer patients Â»hencancer patient 7 (with mÃ©tastases) is removed from the group. PostabsorptiveFluxOxidationSynthesisDegradationFeedingFluxOxidationSynthesisIntakeDegradation11125 . 527 tion of discrete meals. Hence, there is an abrupt switch from the postabsorptive state, in which body stores of fat, glycogen, and protein are utilized as fuels, to the utilization of nutrients from the diet for either oxidation or replenishment of body stores during feeding (26) . Therefore, maintenance of the body reserves of fat and protein requires that the factors controlling these responses to fasting and feeding remain intact. The aim of the present study was to assess the effect of cancer on the metabolic responses to the intake of normal food. This involved measurements in the postabsorptive state followed by a period when regular standard meals were consumed. Previous studies of energy and protein metabolism in cancer patients have made measurements either in the fasted state (1, 4, (6) (7) (8) (9) or when nutrients were given (10, 12, 13) , but there has been no inves tigation of differences in response to nutrient intake. In partic ular, the present patients were given normal food at intakes comparable to those consumed during the period preceding the experiment, when some patients were experiencing weight loss, in contrast to the i.v. or formula feeds given in most other studies (12, 13, 16) .
The patients in the control group, admitted to the hospital for vascular surgery, were selected because of their similarity to the cancer patients. They were of the same age and sex balance and had been in the ward for the same length of time before the study. Habitual diets were similar in energy and protein content, as assessed from dietary histories, and all were drawn from the same geographical area. In particular, the two groups had very similar smoking habits, and both diseases are related to smoking. The mean body weight for the controls was slightly higher than for cancer patients, but the mean LBM was the same. All measured values have been expressed in terms of LBM to allow for the possibility of alterations in body compo sition when weight is lost, as energy expenditure and protein turnover are considered to emanate from the metabolism of non-fat tissue. Thus, it has been shown that differences in energy expenditure between groups of subjects with different proportions of body fat disappear when results are expressed per kg LBM (29, 30). In cancer patients, this method of expressing results would therefore control for differences aris ing simply from differences in body fat.
Measurement of resting energy expenditure per kg LBM showed no difference between the cancer and control patients in the postabsorptive state and in the fed state. The percentage increase in energy expenditure on feeding was the same also (18.2% in cancer patients and 20.2% in controls). Previous work has suggested an elevated REE in cancer patients when rates were related to total body weight (2-4), but no difference between patients with malignant and nonmalignant disease when values were expressed per kg LBM (4, 31, 32) . This suggests that an increase in energy expenditure by lean tissue is not a generalized phenomenon associated with cancer but Table 9 Percentage of energy expenditure from each nutrient during fasting and feeding in control patients The changes in fat and carbohydrate utilization between fasting and feeding are statistically significant, /' < 0.001. The differences between control patients and cancer patients ( does not preclude the possibility of hypermetabolism in certain specific instances (see Ref. 31 ).
We also found the pattern of fat, carbohydrate, and protein utilization in cancer patients to be the same as that in controls. Furthermore, there was very little difference between either of the present groups and the younger, healthy subjects studied previously (26) . A similar lack of effect on nutrient utilization of nonmetastatic tumors has been shown previously (32) . How ever, increases in fat oxidation have been reported in patients with secondary deposits (2, 32) .
Despite the lack of effect of cancer on energy metabolism, we found that whole-body protein turnover rates, expressed per kg LBM, were elevated by comparison with controls in both the fed and the fasted state. By contrast, it has previously been suggested that elevated protein turnover in cancer might only occur in fasting subjects (15) . In both of the present groups, the effect of feeding was to decrease protein breakdown (by 54% in cancer patients and 62% in controls) with no effect on protein synthesis, as has been reported previously (25) . In the cancer group, both synthesis and breakdown were elevated compared with controls so that, unexpectedly, overall balance (synthesis minus breakdown) was identical in the two groups (Fig. 2) .
In other studies on cancer, when increases in whole-body turnover have been reported, results were calculated on the basis of total body weight, with no allowance for possible effects of weight loss on body composition (6, 7, 9, 11) . The present group of cancer patients were not cachexie, in the sense of being wasted or "malnourished," as they had similar values for BMI as the controls and were generally in good health, but six had lost weight. Loss of weight through dietary restriction alone would be expected to lead to decreased rates of protein turnover (27) , suggesting that the observed increase in turnover in cancer patients resulted from the disease itself. Indeed, the occurrence of weight loss in cancer has been suggested as a factor that leads to an increase in protein turnover (10) , although the present data do not lend support to this, as there was no correlation between weight loss and protein turnover rates (see "Results").
The presence of disseminated disease or mÃ©tastaseshas been shown in studies of abdominal cancer to give elevated rates of protein turnover when localized tumors did not (8, 10, 12) . In eight of the present group of lung carcinoma patients, the disease was limited to the chest, and only one (patient 7) had distant mÃ©tastases.However, a significant elevation of wholebody protein turnover rates is still apparent when this subject is omitted from the analysis (see Table 5 ). Furthermore, there were no differences related to the extent of spread within the chest. With lung cancer, therefore, the elevation in rates of whole-body protein turnover can occur without disseminated disease.
No differences in protein turnover related to tumor type or size were detected. It is not possible to discern the contribution of the tumor itself to the observed increase in protein turnover with the whole-body technique, but it seems likely from the estimate of average tumor size of about 100 g that this contri bution would be small. The increase in turnover, therefore, must be in the normal tissues of the host. This is supported by data from experimental animals which have shown an increase 1129 in liver protein synthesis, despite a decrease in skeletal muscle advice during manuscript preparation. The financial support of the (33). Similar increases in whole-body protein turnover rates have been reported during infection (e.g., 34) and pyrexia (35) . In these lung cancer patients, concurrent infection might have contributed to the observed metabolic responses, but none was pyrexial at the time of study. We would expect an increase in whole-body protein turnover to result in an increase in energy expenditure because of the energy cost of peptide bond synthesis. However, it is unlikely that such an increase would have been detectable. Protein turnover has been estimated to contribute about 15% of REE (27) . A 20% increase in whole-body protein turnover would therefore increase REE by only about 3%, which is too small to detect.
Why, then, should some of the patients with lung cancer in this study have lost weight, when there was no demonstrable difference between them and similar controls without cancer, in terms of total energy expenditure, the pattern of nutrient utilization, or the thermogenic response to food intake? Fur thermore, the data showed no difference in protein balance between the two groups. If the observed weight loss of about 0.8 kg/month were entirely from lean tissue, it would amount to no more than 5 g protein per day (i.e., 3 /Â¿mol leucine/kg LBM/h), which is less than 10% of the average rate of leucine oxidation, and about 0.5 kcal/kg LBM/day, which is about 1% of REE. It would not have been possible to detect differences of this magnitude. Even if the loss were entirely from body fat, it would only be equivalent to about 5 kcal/kg LBM/day (i.e., about 12% of measured REE), whereas in practice it is probable that both fat and lean tissue would be lost. The alternative explanation of weight loss is a decrease in dietary intake, which was assessed by diet history. The difficulties of using diet histories have been highlighted before (36), when adequate intakes of energy and protein were reported in weight-losing cancer patients. In the present group of lung cancer patients, both protein and energy intakes were not lower than in the control group, and the differences were not significant. Fur thermore, no significant difference in intake in the ward on the day preceding the study was detected. It was therefore not possible to discern whether weight loss resulted from a change in intake or expenditure. It must, however, be recognized that the imbalance of protein or energy intake and expenditure necessary to account for the observed weight loss is very small and would have been difficult to detect with the number of subjects studied here.
In conclusion, patients with newly diagnosed cancer of the lung showed no abnormalities in total energy expenditure and the relative contributions of fat, carbohydrate, and protein oxidation, or in their responses to the provision of food. Net protein balance was also unaffected by cancer, but whole-body protein turnover rates were elevated. The higher rates were apparent in the fed as well as the fasted state and also after allowing for differences in lean body mass between the cancer and control patients. Furthermore, the elevation in protein turnover occurred in noncachexic patients and did not depend on the occurrence of mÃ©tastases,as had been suggested by earlier studies.
